Synaffix joins forces with Sotio on $740M ADC licensing deal, plans expansion after Lonza acquisition
Lonza’s Synaffix is adding another manufacturing licensing partnership by securing a $740 million deal with Sotio Biotech, which would allow Sotio to use the Dutch company’s three-pronged ADC tech.
It’s been a busy year for Synaffix: It was acquired by Lonza in June and the Sotio deal is its fifth new licensing deal of the year. Synaffix CEO Peter van de Sande told Endpoints News the Lonza acquisition will allow the company to bolster its ADC services. This includes plans to increase its personnel count from 35 to 50 in the next year, as well as expand its facilities and increase its manufacturing R&D capacity.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.